DE3017683C2 - Verwendung eines Extraktes des Giftblaseninhaltes der Biene zur Stimulierung der Immunreaktion - Google Patents

Verwendung eines Extraktes des Giftblaseninhaltes der Biene zur Stimulierung der Immunreaktion

Info

Publication number
DE3017683C2
DE3017683C2 DE3017683A DE3017683A DE3017683C2 DE 3017683 C2 DE3017683 C2 DE 3017683C2 DE 3017683 A DE3017683 A DE 3017683A DE 3017683 A DE3017683 A DE 3017683A DE 3017683 C2 DE3017683 C2 DE 3017683C2
Authority
DE
Germany
Prior art keywords
day
mouse
dose
mice
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3017683A
Other languages
German (de)
English (en)
Other versions
DE3017683A1 (de
Inventor
Toyoo Kanazawa Maeda
Hidetada Mikami
Shohachi Toyama Murakami
Toshinori Hitachi Ohashi
Isamu Saikawa
Hiroshi Takaoka Sakai
Masahiro Takahata
Hisatsugu Toyama Tsuda
Takashi Yasuda
Akira Yotsuji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of DE3017683A1 publication Critical patent/DE3017683A1/de
Application granted granted Critical
Publication of DE3017683C2 publication Critical patent/DE3017683C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3017683A 1979-05-10 1980-05-08 Verwendung eines Extraktes des Giftblaseninhaltes der Biene zur Stimulierung der Immunreaktion Expired DE3017683C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5746179A JPS55149214A (en) 1979-05-10 1979-05-10 Medical composition consisting of extract from liquid in bee poison gland

Publications (2)

Publication Number Publication Date
DE3017683A1 DE3017683A1 (de) 1980-11-20
DE3017683C2 true DE3017683C2 (de) 1985-10-03

Family

ID=13056307

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3017683A Expired DE3017683C2 (de) 1979-05-10 1980-05-08 Verwendung eines Extraktes des Giftblaseninhaltes der Biene zur Stimulierung der Immunreaktion

Country Status (7)

Country Link
US (2) US4370316A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS55149214A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1139660A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3017683C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2455892A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2049423B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1146081B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0086627B1 (en) * 1982-02-12 1985-08-28 Unitika Ltd. Anti-cancer device
US5086002A (en) * 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
US4822608A (en) * 1987-09-14 1989-04-18 Vespa Laboratories, Inc. Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof
AU640611B2 (en) * 1989-04-13 1993-09-02 Vespa Laboratories, Inc. Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
DK82892D0 (da) * 1992-06-24 1992-06-24 Michael Hansen Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
KR19990037902A (ko) * 1999-02-19 1999-05-25 조성구 생봉독을이용한돼지의관절염치료법
KR19990037903A (ko) * 1999-02-19 1999-05-25 조성구 생봉독을이용한신생자돈의면역증진법
KR19990037905A (ko) * 1999-02-19 1999-05-25 조성구 생봉독을이용한돼지의설사병치료법
KR19990037907A (ko) * 1999-02-19 1999-05-25 조성구 생봉독을이용한돼지의유방염치료법
KR100483496B1 (ko) * 2001-09-26 2005-04-19 마응천 봉독 수용성분을 함유하는 소염 및 진통용 조성물
RU2279888C1 (ru) * 2004-11-17 2006-07-20 Вера Николаевна Федосеева Аллергоид из яда пчел для аллерген-специфической иммунотерапии больных с аллергическими реакциями на ужаление пчелами и способ его получения
KR100744755B1 (ko) * 2006-03-31 2007-08-01 권기록 봉독을 이용한 멜리틴의 분리방법
KR100758814B1 (ko) 2006-11-06 2007-09-19 대한민국 봉독의 간이 정제 방법
WO2014003222A1 (ko) * 2012-06-29 2014-01-03 주식회사 청진바이오텍 봉독의 유효성분을 분리하는 방법
US11905317B2 (en) * 2018-12-05 2024-02-20 Ubio Inc. Bee venom-purifying method comprising viral clearance process and composition for preventing or treating inflammatory disease by using same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5457991A (en) * 1977-10-18 1979-05-10 Mitsubishi Electric Corp Laser unit
JPH03299A (ja) 1989-05-26 1991-01-07 Seiko Epson Corp ハンディ機器用定規

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE675605C (de) * 1936-09-11 1939-06-02 August Wolff Sudbracker Naehrm Verfahren zur Trennung und Gewinnung der wertvollen Bestandteile des Bienen- und Schlangengiftes
US2154934A (en) * 1936-09-29 1939-04-18 Hahn Georg Purified bee poison

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5457991A (en) * 1977-10-18 1979-05-10 Mitsubishi Electric Corp Laser unit
JPH03299A (ja) 1989-05-26 1991-01-07 Seiko Epson Corp ハンディ機器用定規

Also Published As

Publication number Publication date
CA1139660A (en) 1983-01-18
GB2049423A (en) 1980-12-31
JPS55149214A (en) 1980-11-20
FR2455892B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-21
US4444753A (en) 1984-04-24
GB2049423B (en) 1984-03-07
FR2455892A1 (fr) 1980-12-05
IT8048633A0 (it) 1980-05-09
DE3017683A1 (de) 1980-11-20
US4370316A (en) 1983-01-25
IT1146081B (it) 1986-11-12

Similar Documents

Publication Publication Date Title
DE3017683C2 (de) Verwendung eines Extraktes des Giftblaseninhaltes der Biene zur Stimulierung der Immunreaktion
DE3689071T2 (de) Immunheilbehandlung.
DE3789239T2 (de) Pharmazeutische Zusammensetzung enthaltend Interferon für bukkale Verabreichung.
DE3227262C3 (de) Verfahren zur Herstellung von menschlichem Tumor-Nekrose-Faktor und menschlicher Tumor-Nekrose-Faktor
Kohchi et al. Applications of lipopolysaccharide derived from Pantoea agglomerans (IP-PA1) for health care based on macrophage network theory
DE69909794T2 (de) Verwendung eines dipeptids für wiederherstellungsprozesse
EP0739630B1 (de) Verfahren zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
DE69632909T2 (de) Verhinderung oder behandlung von schäden des verdauungstraktes auf grund von chemotherapie und bestrahlung
DE2441454A1 (de) Verfahren zur herstellung eines heilmittels fuer leukaemie
DE3011461C2 (de) Verwendung von Propionibakterien
EP1965815B1 (de) Zusammensetzung zur wundheilung, umfassend substanzen aus dipteren-larven
CH452111A (de) Verfahren zur Herstellung eines Impfstoffes
DE2603122B2 (de) Verfahren zum Herstellen von Glykoproteinen sowie deren Verwendung
DE4007315A1 (de) Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen
DE20121186U1 (de) Zusammensetzungen zur Nahrungsmittel- und Tierfutterergänzung
DE3817762C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2639410C2 (de) Polypeptid VI-7501 mit Antitumorwirkung
DE10085492B4 (de) Antimonocytenaktivität von extrakten von Betelpfefferblättern
RU2813777C1 (ru) Способ лечения пастереллеза крупного рогатого скота
DE69334138T2 (de) Biologisch aktive substanz mit immunmodulierenden eigenschaften, verfahren zu ihrer gewinnung und aus ihr hergestellte, pharmazeutische zubereitung
DE2001671C3 (de) Plyvalentes Mastits-Immunglobulin und dessen Verwendung bei der Bekämpfung der Mastits
DE2349186A1 (de) Arzneimittel zur verbesserung der zellatmung, der herzmuskelleistung und der hirnfunktion und verfahren zu seiner herstellung
US20240173373A1 (en) Novel method for the production of concentrated aloe vera compositions and therapeutic uses for the same
DE1617950A1 (de) Verfahren zur Beeinflussung der Immunitaet oder Widerstandskraft eines Wirtsorganismus
DE3249946C2 (de) hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee